CELCUITY INC. - COMMON

Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call

07 نوفمبر 2024 07:05:00 بحسب Nasdaq GlobeNewswire

Celcuity Inc. Reports Second Quarter Financial Results and Provides Corporate Update

14 أغسطس 2024 16:01:00 بحسب Nasdaq GlobeNewswire

Celcuity Inc. Schedules Release of Second Quarter 2024 Financial Results and Webcast/Conference Call

07 أغسطس 2024 07:05:00 بحسب Nasdaq GlobeNewswire

Celcuity To Participate in Jefferies Global Healthcare Conference

03 يونيو 2024 16:01:00 بحسب Nasdaq GlobeNewswire

Celcuity Announces Pricing of Underwritten Common Stock Offering

30 مايو 2024 07:36:22 بحسب Nasdaq GlobeNewswire

Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing

30 مايو 2024 07:00:01 بحسب Nasdaq GlobeNewswire

Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update

15 مايو 2024 16:01:00 بحسب Nasdaq GlobeNewswire

Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call

08 مايو 2024 07:05:00 بحسب Nasdaq GlobeNewswire

Celcuity To Present at Upcoming Needham and Stifel Investor Conferences

04 أبريل 2024 07:05:00 بحسب Nasdaq GlobeNewswire

Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

27 مارس 2024 16:01:00 بحسب Nasdaq GlobeNewswire

Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call

20 مارس 2024 07:05:00 بحسب Nasdaq GlobeNewswire

Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024

06 مارس 2024 07:05:00 بحسب Nasdaq GlobeNewswire

Celcuity to Participate in Cowen’s 44th Annual Health Care Conference

28 فبراير 2024 07:05:00 بحسب Nasdaq GlobeNewswire

Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer

22 فبراير 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Celcuity Appoints Eldon Mayer as Chief Commercial Officer

20 فبراير 2024 07:05:00 بحسب Nasdaq GlobeNewswire

Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium

06 ديسمبر 2023 08:30:00 بحسب Nasdaq GlobeNewswire

Celcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposium

01 ديسمبر 2023 11:02:45 بحسب Nasdaq GlobeNewswire

Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference

22 نوفمبر 2023 08:05:00 بحسب Nasdaq GlobeNewswire

Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

13 نوفمبر 2023 07:05:00 بحسب Nasdaq GlobeNewswire

Celcuity Inc. Schedules Release of Third Quarter 2023 Financial Results and Webcast/Conference Call

06 نوفمبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire